Skip to content
ClinCalc Pro
Menu
Potassium replacement

Potassium chloride

Brand names: Sando-K, Slow-K, Kay-Cee-L

Potassium chloride is a potassium supplement used to prevent or treat hypokalaemia; oral modified-release formulations and carefully controlled intravenous infusions are both available.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It replaces the potassium ion, the principal intracellular cation essential for nerve conduction, muscle contraction and cardiac rhythm, correcting a deficit and its associated effects.

Prescribing in practice

  • Intravenous potassium chloride must always be diluted and infused slowly with cardiac monitoring, as bolus or concentrated administration can cause fatal cardiac arrest; this is a recognised never-event hazard.
  • Use cautiously in renal impairment and with potassium-sparing diuretics, RAS inhibitors or aldosterone antagonists because of the risk of hyperkalaemia.
  • Oral modified-release tablets should be swallowed whole with plenty of fluid, ideally sitting or standing, to limit gastrointestinal ulceration.

Monitoring

Monitor serum potassium and renal function, with continuous ECG monitoring during intravenous replacement.

Counselling the patient

  • Swallow the tablets whole with a full glass of water and do not crush or chew them.
  • Report muscle weakness, palpitations or tingling, which may signal too much potassium.

Evidence & guidelines

Its role in correcting potassium deficits is well established, with current prescribing references and the SPC emphasising the dangers of inappropriate intravenous administration.

Reference: NICE NG29; UK guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.